Natera going with an IPO?

Quote







On pages F-47/F-48 of the S-1 filing, it is written:

For example, in November 2014, a third-party payer sought information as part of an investigative audit of claims which they had paid for certain genetic testing. The Company complied with their request and provided responsive information. In a letter dated June 2, 2015, the third-party payer alleged that it had overpaid $1.88 million to the Company. We disagree with its contentions and are in active discussions with this payer to resolve its concerns.

Anyone know anything about this?
 



Anonymous said:
On pages F-47/F-48 of the S-1 filing, it is written:

For example, in November 2014, a third-party payer sought information as part of an investigative audit of claims which they had paid for certain genetic testing. The Company complied with their request and provided responsive information. In a letter dated June 2, 2015, the third-party payer alleged that it had overpaid $1.88 million to the Company. We disagree with its contentions and are in active discussions with this payer to resolve its concerns.

Anyone know anything about this?
Click to expand...

1.88M from a 3rd party...that's petty cash in the grand scheme of things. Nothing to worry about.
 












Anonymous said:
You actually made a compelling case. All the way till the very end. You write with some degree of intelligence and then you completely discredit yourself with "sux". You wrote all those words in their full length with little to no spelling mistakes and on the very last word you decided to pull the plug on literacy. Did you get in a hurry? Maybe spelling out the full word would take too long? I mean, now I just think you are in high school with a very sharp understanding of the politics in play at Natera, some how? I don't know, either way, you blew it. Maybe that's how your sales calls go? You have the doctors until the very end, and then you blow it. Bad numbers. Bad paycheck. Bad attitude. Just quit already before you are apart of the first "realignment" coming soon.
Click to expand...

Little to no spelling mistakes? You're all idiots...how can you "loose a race"? And it seems that no one on here understands the difference between their, there, and they're.
 






Anonymous said:
1.88M from a 3rd party...that's petty cash in the grand scheme of things. Nothing to worry about.
Click to expand...

Or this could be the tip of the iceberg. Many of you may remember Jane Pine Wood from McDonald Hopkins. Earlier this year, she wrote: “Both CIGNA and Aetna have sent letters to laboratory clients of mine refusing to make payment until the clients have presented evidence of collection of the full out of network balance from the patient. That’s a real game changer. It’s one thing to assume the business risk of periodic reductions of patient balances or adopting an internal policy of less aggressive billing and collection efforts. It’s quite different if the payor refuses to pay the laboratory a penny until it has been presented evidence of the collection of the full balance owed by the patient.”

Full link here:
http://pathologyblawg.com/pathology...-exclusive-laboratory-arrangement-ruling-oig/
 









Anonymous said:
I can agree with a lot of what you are saying, but not all of it. Also, any company filing for IPO generally does so with a strong pipeline and business plan moving forward. The like of Goldman and Morgan Stanley wouldn't even entertain us if not for a strong financial plan looking into 2016/2017/2018. You make a lot of mention on NIPT and Carrier screening but fail to mention the companies oncology division. Rest assured, the hopes and dreams of the IPO and Natera rest in the hands of that division and how well the tests perform. That's what the stock price will be built on and continue to grow on. 6 months the stock price will still be high. It's after the oncology division shows clinical validation (or doesn't) that something might change significantly.
Click to expand...

Stupid fuck. Now you see how much their stock price dropped?
 



It's hard to believe the morons on this board, it's apparent the natera management completely misled the market on the number of new number of tests performed vs the number ordered. It's really an old lab scam of bundedled vs non bundedled. Most payers will only pay non bundled claims so that means 70% of your revenue is bs and will never be paid. Short baby short
 



Anonymous said:
Both are valid statements, but no need to be condescending with your reply. Not everyone understands how this works. The fundamental issue Natera will face post IPO is that the growth rates can not be sustained long term. Here is why:

1. The market is saturated right now and Natera has over expanded the sales force. Senior management knows this and has begun selectively collapsing vacant territories (Indiana/Michigan not being filled). They also know that the monster growth expectations set quarter over quarter have hit the pinical with Q-2 goals (80-85% of sales force not going to hit goal), and they know SPIFS are more about luck and timing than about performance. Strong reps are already planning exit strategies.

2. Reimbursement nightmare is just beginning. Management needs continued 35% growth quarter over quarter to make up for losses on existing sales. We are loosing revenue on 70% of all NIPT tests that are processed. Now we are having billing push to get more money from patients when they call in. We have abandoned the $25, and the $100, as well as the " we will accept what you patient can afford" and the " billing will not attempt to negotiate" strategies. We are now asking for $200 if a patient says they can afford $100. It will only get worse. An RD in the East told a rep that "even if a new account is 100% Medicaid to go ahead and take the kits now because we need the volume now". It is a house of cards with our billing structure.

3. The IPO will generate $$$$$ based on share price and volume, but only in the short run. Anyone remember what the initial price of Facebook was? What it dropped to within 30 days? Where it trades today? The initial pop will be nice for Natera, but by the time the 6 month trading block expires and most employees will be allowed to sell their shares....the price will have settled in much lower that the I itial IPO price. That is because Wall Street will have discovered that NIPT is loosing more than it can bring in on growth, and that an $11,000+ Carrier Screening test will not be loved by insurance companies. Once the stock settles in at <$10.00 a share in December, all hell will break loose. Rep layoffs and cost control measures in order to get someone to come buy them.

Rest assured, by this time next year, Natera will no longer be Natera. But by then, DC, PE, KS and PM will have moved on to the next company to destroy...I mean build out. All under the leadership of SC. But I'm sure they will take everyone with them.
Click to expand...
 





LOL......I said back in February most of what is happening now would occur. Then, some company knuckle-head came here and was telling everyone how different and wonderful all will be.
 






Anonymous said:
I show that paper all the time and I work for Natera. Doctors laugh when they realize the incidence rate of T21 would have to be 1/4 for those numbers to hold water. Puffery at its finest and no one is falling for it. Cute. Nice try.
Click to expand...

Ummm- that review does not even talk about PPV. It can't since it is only looking a patients who had a positive result. The objective was to determine false positives vs true positives among different NIPT... And NEJM is quite credible.
 



Anonymous said:
One trick ponies like Axovant Sciences? IPO happened today and went up 99%! They won't have a product to market for another 3-5 years! Natera already has multiple products to market with multiple products in the pipeline...... that's a lot better story. Link below to the non believers.

http://www.cnbc.com/id/102753274
Click to expand...

Here's another story about Axovant - see chart #7 about the IPO Class of 2015

http://www.bloomberg.com/news/artic...ts-you-need-to-understand-health-care-in-2016
 






Top Bottom
Back
Quote